Your browser doesn't support javascript.
loading
Nanoparticles targeting the intestinal Fc receptor enhance intestinal cellular trafficking of semaglutide.
Pinto, Soraia; Hosseini, Mahya; Buckley, Stephen T; Yin, Wen; Garousi, Javad; Gräslund, Torbjörn; van Ijzendoorn, Sven; Santos, Hélder A; Sarmento, Bruno.
Afiliação
  • Pinto S; Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal; Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, Rua Jorge de Viterbo Ferreira 228, 4050-313 Porto, Portugal.
  • Hosseini M; Department of Biomedical Sciences of Cell and Systems, Section Molecular Cell Biology, University Medical Center Groningen, University of Groningen, 9713, AV, Groningen, the Netherlands.
  • Buckley ST; Global Research Technologies, Novo Nordisk, Novo Nordisk Park 1, 2760 Måløv, Denmark.
  • Yin W; Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Roslagstullsbacken 21, 114 17 Stockholm, Sweden.
  • Garousi J; Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Roslagstullsbacken 21, 114 17 Stockholm, Sweden; Department of Immunology, Genetics and Pathology, Uppsala University, 75185 Uppsala, Sweden.
  • Gräslund T; Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Roslagstullsbacken 21, 114 17 Stockholm, Sweden.
  • van Ijzendoorn S; Department of Biomedical Sciences of Cell and Systems, Section Molecular Cell Biology, University Medical Center Groningen, University of Groningen, 9713, AV, Groningen, the Netherlands.
  • Santos HA; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5E, Helsinki FI-00014, Finland; W.J. Kolff Institute for Biomedical Engineering and Materials Science, University Medical Center Groningen, University of Groningen, 97
  • Sarmento B; Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal; Instituto Universitário de Ciências da Saúde (IUCS-CESPU), Rua Central de Gandra 1317, 4585-116 Gandra, Portugal. Electronic address: bruno.sarmento@i3s.up.pt.
J Control Release ; 366: 621-636, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38215986
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Diabetes Mellitus Tipo 2 / Peptídeos Semelhantes ao Glucagon / Nanopartículas / Lactatos Limite: Humans / Newborn Idioma: En Revista: J Control Release Assunto da revista: FARMACOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Portugal
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Diabetes Mellitus Tipo 2 / Peptídeos Semelhantes ao Glucagon / Nanopartículas / Lactatos Limite: Humans / Newborn Idioma: En Revista: J Control Release Assunto da revista: FARMACOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Portugal